Q3 FINANCIAL INFORMATION

The LISI Group posted consolidated sales of €1,323.0m for the first nine months of 2024 up +8.6% compared with 2023

n  LISI AEROSPACE: business remains buoyant in all segments of the aerospace market, with growth in excess of 20%.

n  LISI AUTOMOTIVE: the ramp-up of new products partly offsets the downturn in the global automotive market, which has worsened since the start of the third quarter.

n  LISI MEDICAL: after an exceptionally high level of sales last year, business stabilized in the third quarter ; the medium-to-long-term outlook remains solid.

Consolidated sales for the first nine months of the year came to €1,323.0m, up +8.6% on the same period of 2023, and include the following items:

•     an unfavorable currency effect of - €3.9 million (0.3% of sales), mainly due to the weakening of the average US dollar rate against the euro,

•     a price effect valued at around €40.0 million, linked to the partial passthrough to customers of inflation on manufacturing costs.

Third-quarter growth was +5.9% compared with the same period last year.

Adjusted for exchange rate variations and with no scope effects, sales rose by

8.9% over the first nine months of the year, and by 6.4% in the third quarter.

1 The change at constant scope and exchange rates is calculated:

•   by converting the sales of the companies whose financial statements are denominated in foreign currencies at the average rate of the year N-1 or the month M-1;

•   by converting the sales invoiced in currencies other than the local currency at the average rate of the previous year or previous month M-1;

•   by restating the entries into or exits from the scope to ensure comparability of data.

COMMENTS BY BUSINESS SECTOR

LISI AEROSPACE (56% of consolidated total)

•     Business continues to grow

The resilience of the global commercial aeronautics market is reflected in high order levels, particularly at Airbus. Nevertheless, production rate increase ambitions have been postponed due to tensions throughout the aeronautical supply chain. However, they are increasing for the Airbus A320 family (currently 58 aircraft, with a target of 75 by 2026). The strike at Boeing since early September has halted assembly of the B737 MAX (around 38 aircraft per month). Although this stoppage has not yet had a significant impact on LISI AEROSPACE in the third quarter, it will weigh on general demand.

Orders for long-haul aircrafts, as well as the good performance of the helicopter and military market segments, provide long-term visibility.

•     The "Fasteners" business remains the main beneficiary of the ramp-up in single-aisle production

LISI AEROSPACE division sales came to €742.2m in the first nine months of Sales in million euros 2024, up +20.7% on the same period in 2023.

End of September

The third quarter of 2024 saw continued dynamic growth of +18.5% compared with 2023, slowed, however, by bottlenecks in certain engine products. In addition, the division is continuing discussions to factor in the effects of inflation. The "Fasteners" business continued to benefit from the ramp-up in single-aisle aircraft production rates, and from strong demand for maintenance services linked to the sustained traffic in the commercial aircraft fleet. Third-quarter sales rose by +26.8% in Europe and +22.0% in the United States, despite an unfavorable currency effect. The "Structural Components" business is up +4.8% after a year of sustained growth in 2023 (+10.1% in Q3 2023).

Sales growth for the LISI AEROSPACE division, restated for currency variations and in the absence of perimeter effects, came to +18.7% in the third quarter of 2024 compared with the same period last year (+19.0% cumulatively to September 30, 2023).

AEROSPACE          AUTOMOTIVE              MEDICAL

LISI AUTOMOTIVE (34% of consolidated total)

Sharp slowdown in the global market

The global automotive market contracted by 4.7% in the third quarter compared with the same period last year, ending eight consecutive quarters of growth. The slowdown that began at the end of the second quarter of 2024 is confirmed and accelerating.

Worldwide sales of light vehicles, expressed in number of registrations, fell sharply over the quarter, in China (-7.9%), Europe (-6.5%) and NAFTA zone (-1.0%), penalized by the contraction in sales of electric vehicles.

Third-quarter sales down

LISI AUTOMOTIVE division sales came to €447.2m in the first nine months of 2024 (down 4.6% on the same period in 2023). This takes into account the accelerated decline in sales in the third quarter (-9.1% compared with the same period last year), particularly noticeable among OEMs.

Restated for currency variations and in the absence of scope effects, LISI AUTOMOTIVE division sales fell by -8.2% over the third quarter. Compared with the

-7.4% drop in global production by the division's customers since the start of the year, the -4.1% decline in sales for the division over the first nine months attests not only to its resilience, but also to further gains in market share with automakers.

                                                                                              •    Good momentum in new product orders

Order intake for new products remained at the high level of 12.2% of sales for the first nine months of the year (12.9% for the same period last year), or around €54.0 million (€60.4 million for the same period last year). With this performance, the LISI AUTOMOTIVE division continues to demonstrate its ability to anticipate technological developments in the automotive industry, and to consolidate its competitive

% Sales Variation per division / N-1 differentiation in a market undergoing profound change.

     LISI MEDICAL (10% of consolidated total)

The global implant market continues to be driven by technological innovation, in a context of dynamic demand offering good visibility.

² Source ACEA

Unfavorable basis of comparison and raw materials supply difficulties

LISI MEDICAL division sales came to €134.3m in the first nine months of 2024. They were virtually stable (-0.6%) compared with the same period in 2023, when they rose by +22.2%. In addition to this unfavorable comparison base effect, production was disrupted by raw material supply difficulties.

Restated for currency variations and in the absence of any scope effects, LISI

MEDICAL division sales rose by +0.8% over the quarter, and fell slightly by -0.3% over the first nine months of the year.

OUTLOOK AND COMMENTS ON FINANCIAL IMPACT ACTIVITY

LISI AEROSPACE

In civil aeronautics, and particularly in the Airbus ecosystem, demand remains buoyant. It is benefiting from the dynamism of maintenance, linked to the high level of traffic in the commercial aircraft fleet. The book-to-bill ratio remains well above 1. All other market segments - with the exception of Boeing - including helicopters and the military (15% of LISI AEROSPACE sales), are also very dynamic and offer good longterm visibility.

The focus in the fourth quarter will be on:

•  control of manufacturing levels to cope with increases in demand, while adapting to the likely effects of the strike at US aircraft manufacturer Boeing, which could lead to sharp adjustments in demand,

•  inventory reduction,

•  continued negotiations with major customers concerning delayed compensation for the effects of inflation.

LISI AUTOMOTIVE

The slowdown observed by LISI AUTOMOTIVE's main customers is set to continue in the final quarter, in a market undergoing profound technological and geographical change. In addition, there is strong pressure on prices throughout the automotive industry, with the drive to lower manufacturing costs for electric vehicles. The industry's move towards 100% electric vehicles has turned into a battle of costs.

The LISI AUTOMOTIVE division will therefore have to continue to demonstrate discipline and adaptation, while ensuring the development and ramp-up of new

                   « Shape and Share                products resulting from the record order intake of recent years. It is however possible

that the realization of current projects, in particular applications for electric vehicles,

                   Sustainable Links »              will _{be delayed.}

LISI MEDICAL

Long-term growth prospects for minimally invasive robotic surgery and orthopedic reconstruction remain good. The division continues to benefit from a solid order book. In the fourth quarter, priority will be given to the continued development of new products and the ramp-up of production volumes, supported by the expansion of the Minneapolis site (USA). Resolving the operational difficulties linked to the shortage of raw materials will still be a point of focus.

LISI CONSOLIDATED

Emmanuel VIELLARD Although aerospace growth will logically remain buoyant over the coming quarters, the impact of the Boeing strike will be felt by LISI AEROSPACE's business exposed

CEO to these programs. In addition, the evolution of the automotive market creates an email: emmanuel.viellard@lisi-group.com element of uncertainty regarding the possible postponement of new projects currently

( : +33 3 84 57 00 77 - www.lisi-group.com in industrialization.

At this stage and at constant exchange rates, the Group still confirms the objective set on February 22, 2024 when it published its 2023 annual results, namely to

.

² Free Cash Flow: net operating cash flow minus net CAPEXimprove its EBIT and generate positive Free Cash Flow.

and changes in working capital requirements